Universitätsklinikum Schleswig-Holstein (UKSH)

Update Breast Cancer 2022 Part 4 - Advanced-Stage Breast Cancer. (2022) Aktas B, Fehm TN, Welslau M, Mueller V, Lueftner D, Schuetz F, Fasching P, et al. Journal article, Review article Update Breast Cancer 2022 Part 1 - Early Stage Breast Cancer. (2022) Welslau M, Mueller V, Lueftner D, Schuetz F, Stickeler E, Fasching P, Janni W, et al. Journal article, Review article Update Breast Cancer 2022 Part 3 - Early-Stage Breast Cancer. (2022) Fehm TN, Welslau M, Mueller V, Lueftner D, Schuetz F, Fasching P, Janni W, et al. Journal article, Review article Experimental in vitro, ex vivo and in vivo models in prostate cancer research (2022) Sailer V, von Amsberg G, Duensing S, Kirfel J, Lieb V, Metzger E, Offermann A, et al. Journal article, Review article Impact of age on outcome of CAR-T cell therapies for large B-cell lymphoma: the GLA/DRST experience (2022) Dreger P, Holtick U, Subklewe M, von Tresckow B, Ayuk F, Wagner E, Wulf G, et al. Journal article Prognosis of Patients With Primary Melanoma Stage I and II According to American Joint Committee on Cancer Version 8 Validated in Two Independent Cohorts: Implications for Adjuvant Treatment. (2022) Garbe C, Keim U, Amaral T, Berking C, Eigentler TK, Flatz L, Gesierich A, et al. Journal article Real-world data on the effectiveness, safety and drug survival of dupilumab: an analysis from the TREATgermany registry (2022) Stoelzl D, Sander N, Heratizadeh A, Haufe E, Harder I, Abraham S, Heinrich L, et al. Journal article Long-Term Results of Allogeneic Stem Cell Transplantation in Adult Ph- Negative High-Risk Acute Lymphoblastic Leukemia (2022) Beelen DW, Arnold R, Stelljes M, Alakel N, Brecht A, Bug G, Bunjes D, et al. Journal article Intensified cytarabine dose during consolidation in adult AML patients under 65 years is not associated with survival benefit: real-world data from the German SAL-AML registry (2022) Hanoun M, Ruhnke L, Kramer M, Hanoun C, Schaefer-Eckart K, Steffen B, Sauer T, et al. Journal article Lessons learned after one year of COVID-19 from a urologist and radiotherapist view: A German survey on prostate cancer diagnosis and treatment (2022) Harke NN, Wagner C, Hermann RM, Hadaschik BA, Radtke JP, Altay-Langguth A, Aufderklamm S, et al. Journal article